Munoth Commun. (511401)
Asset PlayScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹12.24 |
| Market Cap | ₹11.87 Cr |
| P/E Ratio | 0 |
| ROCE | -2.03% |
| ROE | -5.17% |
| Dividend Yield | 0% |
| Profit Growth | -117.65% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹5.65 — ₹13.3 |
| Sector | Finance |
| Book Value | ₹16.07 |
Strengths
- Trades at a 24% discount to stated book value (P/B 0.76 against BV ₹16.07 and price ₹12.24).
- Positive stated book value of ₹16.07 could provide an asset backstop if the assets are genuine and realizable.
- Small market cap of ₹12 Cr allows a relatively small capital infusion or business revival to move per-share value materially.
- Reported latest-quarter net loss rounds to ₹0 Cr, indicating very small absolute losses at the current shell level.
Concerns
- Zero sales in the latest quarter and no earnings (P/E 0.00), so there is no operating business to value.
- Profit growth of -117.65% and negative ROE of -5.17% show deteriorating profitability and shareholder-value destruction.
- Piotroski F-Score of 2/9 indicates poor financial health; the company fails most basic quality tests.
- No dividend, no promoter-holding data, and N/A debt/equity leave critical governance and solvency questions unanswerable.
AI Analysis
Let us start with what I understand. Munoth Commun is a tiny financial-services listing selling at ₹12.24, with a market value of ₹12 Cr and a stated book value of ₹16.07 per share. On surface, I am buying a rupee of assets for seventy-six paise. That would have caught Graham's eye. But Benjamin Graham also said the investor's chief problem is himself. I must not mistake a headline discount for deep value. This company has no sales. The latest quarter shows sales of ₹0 Cr and a net profit that rounds to ₹0 Cr—meaning no income engine at all. Return on equity is -5.17%, and ROCE is -2.03%. Profit growth is -117.65%, so whatever earnings existed, they have collapsed into deeper losses. Piotroski F-Score of 2/9 adds to the smell: on nine financial-health tests, this company fails seven. A low price-to-book is only attractive if the book is honest and the assets can earn. Here, the assets earn nothing. There is no dividend, no promoter-holding disclosure, and the FairStock Score says insufficient data. So what am I buying? A cigar butt with perhaps one puff left, and even that puff is uncertain. The 52-week range ₹5.65 to ₹14.50 shows Mr. Market has no clear view. In India, small financial-services shells can turn into operating businesses, but that is speculation, not investing. If the book value is real and there is hidden asset value, this is an asset play. But I would demand a much larger margin of safety than a 24% discount before committing hard-earned capital. The price may be cheap, but cheap can become cheaper when the business earns zero returns. I prefer profitable businesses with moats and management I can trust. This one fails that test; I will pass.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer